For the stimulatory immune checkpoints, PSMB9 was similarly strongly associated with most stimulatory checkpoints involved in anti-tumor functions, including IL2, TNFSF4, GZMA, CD27, CCL5, IFNG, ICAM1, CD28, and CD40LG, across nearly all tumor types. This evidence concerns the gene ICAM1 and neoplasm.